Next Article in Journal
RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12, 485
Next Article in Special Issue
Hypoxia-Activated Theragnostic Prodrugs (HATPs): Current State and Future Perspectives
Previous Article in Journal
PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(2), 188; https://doi.org/10.3390/pharmaceutics16020188
Action Date Notes Link
article xml file uploaded 29 January 2024 04:28 CET Original file -
article xml uploaded. 29 January 2024 04:28 CET Update https://www.mdpi.com/1999-4923/16/2/188/xml
article pdf uploaded. 29 January 2024 04:28 CET Version of Record https://www.mdpi.com/1999-4923/16/2/188/pdf
article html file updated 29 January 2024 04:30 CET Original file https://www.mdpi.com/1999-4923/16/2/188/html
Back to TopTop